- Home
- CAPR vs ASPI Comparison
CAPR vs ASPI Comparison
Compare CAPR & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- ASPI
- Stock Information
- Founded
- CAPR 2005
- ASPI 2021
- Country
- CAPR United States
- ASPI United States
- Employees
- CAPR N/A
- ASPI N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- ASPI Major Chemicals
- Sector
- CAPR Health Care
- ASPI Industrials
- Exchange
- CAPR Nasdaq
- ASPI Nasdaq
- Market Cap
- CAPR 622.9M
- ASPI 476.8M
- IPO Year
- CAPR N/A
- ASPI 2022
- Fundamental
- Price
- CAPR $12.79
- ASPI $3.92
- Analyst Decision
- CAPR Strong Buy
- ASPI Strong Buy
- Analyst Count
- CAPR 7
- ASPI 2
- Target Price
- CAPR $39.29
- ASPI $4.50
- AVG Volume (30 Days)
- CAPR 1.5M
- ASPI 1.6M
- Earning Date
- CAPR 03-19-2025
- ASPI 04-09-2025
- Dividend Yield
- CAPR N/A
- ASPI N/A
- EPS Growth
- CAPR N/A
- ASPI N/A
- EPS
- CAPR N/A
- ASPI N/A
- Revenue
- CAPR $23,228,045.00
- ASPI $3,383,374.00
- Revenue This Year
- CAPR N/A
- ASPI $865.76
- Revenue Next Year
- CAPR $74.85
- ASPI $700.00
- P/E Ratio
- CAPR N/A
- ASPI N/A
- Revenue Growth
- CAPR 65.33
- ASPI N/A
- 52 Week Low
- CAPR $3.52
- ASPI $1.86
- 52 Week High
- CAPR $23.40
- ASPI $9.33
- Technical
- Relative Strength Index (RSI)
- CAPR 42.76
- ASPI 40.74
- Support Level
- CAPR $11.75
- ASPI $3.71
- Resistance Level
- CAPR $16.17
- ASPI $4.33
- Average True Range (ATR)
- CAPR 1.51
- ASPI 0.50
- MACD
- CAPR -0.18
- ASPI -0.04
- Stochastic Oscillator
- CAPR 22.96
- ASPI 15.34
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.